FDA Green Lights Domestic Inspections Beginning 2/7

FDA says it is lifting its domestic inspection pause and will resume conducting inspections in the U.S beginning 2/7 across all commodities now that Covid-19 cases are dramatically declining. “In addition to the resumption of planning and conducting domestic surveillance inspections on 2/7, the FDA continues to conduct both foreign and domestic mission-critical inspections, as well as provide effective oversight of foods, drugs, medical products and tobacco leveraging a variety of tools, including remote assessments,” it says.

Regarding foreign inspections, the agency says it is continuing to proceed with previously planned foreign surveillance inspections that have received country clearance and are within the Center for Disease Control and Prevention’s Level 1 or Level 2 Covid-19 travel recommendation. “Planning for additional foreign surveillance inspections is ongoing, with an anticipated goal of conducting foreign prioritized inspections starting in April,” it says.